Pregnolia AG

medical devices

About

Pregnolia AG is a Swiss medtech company focused on women's health, particularly in improving pregnancy care. Founded in 2016 as a spin-off from ETH Zurich, the company specializes in developing diagnostic devices that predict the risk of premature birth by measuring cervical stiffness. This proprietary technology is CE-marked and designed for point-of-care use, allowing healthcare providers to obtain quick and reliable measurements during routine pregnancy consultations. The team at Pregnolia combines scientific, technical, and medical expertise, led by CEO Dr. Sabrina Badir and VP of R&D Dr. Francisco Delgado. The company is compliant with EN ISO 13485:2021 quality management standards and has raised approximately CHF 6.6 million to support product development and market expansion, including entry into the US market. Pregnolia's mission is to enhance pregnancy care through innovative diagnostics, ultimately aiming to reduce the incidence and consequences of premature births.

Technologies

Gmail Google Apps Google Cloud Hosting Google Dynamic Remarketing DoubleClick Conversion Google Tag Manager Wix Varnish DoubleClick Google Analytics Mobile Friendly Remote AI

Keywords

medical devices medical equipment manufacturing biotechnology clinical studies cervical stiffness measurement obstetrics gynecology biomechanical assessment medical device innovation medical equipment and supplies manufacturing preterm birth risk assessment medical device b2b e-commerce risk prediction single-use probe biomechanics during pregnancy eth research research and development prenatal diagnostics early detection of preterm labor pregnancy care ce certified healthcare control unit objective cervical assessment services manufacturing distribution hospital & health care

Location

33 Wiesenstrasse, Schlieren, Zurich, Switzerland, 8952

Related Companies

Companies in the same industry